Communicable Diseases Intelligence Quarterly Report 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.National Notifiable Diseases Surveillance System, 1 April to 30 June 2017.
Authors: Office of Health Protection, Department of Health
Abstract
A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 75,935 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 April to 30 June 2017 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.
PMID: 29864397 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - June 6, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
National Notifiable Diseases Surveillance System, 1 July to 30 September 2017.
Authors: Office of Health Protection, Department of Health
Abstract
A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 267,220 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 July to 30 September 2017 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.
PMID: 29864398 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - June 6, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
National Notifiable Diseases Surveillance System, 1 October to 31 December 2017.
Authors: Office of Health Protection, Department of Health
Abstract
A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 80,388 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 October to 31 December 2017 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.
PMID: 29864399 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - June 6, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Tuberculosis screening in an aged care residential facility in a low-incidence setting.
Authors: Moyo N, Trauer J, Trevan P, Baker AM, Musemburi J, McGrath K, Nolan A, McIntyre E, Hulls J, Denholm JT
Abstract
Tuberculosis (TB) remains a disease of high morbidity in Australia, with implications for both public health and the individual. Cost analyses is relevant for programmatic evaluation of TB. There is minimal published TB cost data in the Australian setting. Patients with drug sensitive active pulmonary TB (DS-PTB) and latent TB (LTBI) were enrolled in a single tertiary referral centre to evaluate healthcare provider costs. The median cost of treating drug susceptible pulmonary TB in this ...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Prevention of perinatal hepatitis B virus transmission: are we following guidelines?
Authors: Markey PG, White HA, Matthews AT, Strebor CR, Krause V
Abstract
It is recommended that infants born to women with hepatitis B infection should have serological review following completion of a four dose vaccination schedule. A review was undertaken on 102 neonates who received hepatitis B immunoglobulin to ascertain the proportion that were fully immunised and then followed up. Of the 66 infants for whom data were available, 65 (98.5%) had appropriately received four doses of hepatitis B vaccine in infancy and a further child had received three doses. Only 19/66 (29%; 95%CI: 18-41%) infants had do...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia.
Authors: Waring J, Waring J, National Tuberculosis Advisory Committee
Abstract
Tuberculosis (TB) is uncommon in Australia and not commonly managed by most healthcare workers (HCWs). However, even in a low incidence setting, occasional exposure of HCWs is inevitable and transmission of TB to HCWs leading to disease does occur. In addition, HCWs may have been recruited to Australia from countries with high TB incidence. These HCWs are more likely to be infected with TB before arrival and subsequently develop active disease while working in health settings in Australia. In 2001, there were 20 TB notifications...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
National position statement for the management of latent tuberculosis infection.
CONCLUSION: The diagnosis and treatment of LTBI represents an important opportunity for intervention by jurisdictional TB control programs.
PMID: 29720068 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
How much does tuberculosis cost? An Australian healthcare perspective analysis.
Authors: Chan E, Nolan A, Denholm J
Abstract
Tuberculosis (TB) remains a disease of high morbidity in Australia, with implications for both public health and the individual. Cost analyses is relevant for programmatic evaluation of TB. There is minimal published TB cost data in the Australian setting. Patients with drug sensitive active pulmonary TB (DS-PTB) and latent TB (LTBI) were enrolled in a single tertiary referral centre to evaluate healthcare provider costs. The median cost of treating drug susceptible pulmonary TB in this case series was 11,538 AUD. Approximately 50% of total costs is derived from...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Sexually Transmitted Infections in Melbourne, Australia from 1918 to 2016: nearly a century of data.
Conclusions: Both antibiotics and changing sexual behaviour have had a powerful effect on STI rates. These data suggest gonorrhoea is more difficult to control than syphilis or chancroid. Indeed, the past rates suggest substantial endemic gonorrhoea transmission in heterosexuals occurred in the third quarter of last century before the appearance of the HIV pandemic. Worryingly, there is a suggestion that endemic heterosexual gonorrhoea may be returning. The data also suggest that future control of gonorrhoea and syphilis in men who have sex with men is going to be challenging.
PMID: 29720070 [PubMed - in process] (...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
The effects of culture independent diagnostic testing on the diagnosis and reporting of enteric bacterial pathogens in Queensland, 2010 to 2014.
Authors: May FJ, Stafford RJ, Carroll H, Robson JM, Vohra R, Nimmo GR, Bates J, Kirk MD, Fearnley EJ, Polkinghorne BG
Abstract
Changes in diagnostic laboratory testing procedures can impact on the number of cases notified and the public health surveillance of enteric pathogens. Culture independent diagnostic testing using a multiplex polymerase chain reaction (PCR) test was introduced for the rapid detection of bacterial enteric pathogens in pathology laboratories in Queensland, Australia, from late 2013 onwards. We conducted a retrospective descriptive study using laboratory data to assess the impact of t...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
The epidemiology of tuberculosis in the Australia Capital Territory, 2006-2015.
Conclusion: There was an increasing trend in the number of TB notifications in the ACT over the study period. The highest rate of TB notifications remained in the overseas-born population; with other studies suggesting this is commonly due to reactivation of latent tuberculosis infection (LTBI). As Australia starts working towards TB elimination, options for the screening and management of LTBI, especially in high risk populations, need to be explored.
PMID: 29720072 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017.
Authors: Lahra MM, Enriquez R
Abstract
The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and by non-culture based techniques. Data contained in quar-terly reports are restricted to a description of the number of cases of IMD by jurisdiction and serogroup, where known. A full analysis of laboratory confirmed cases of IMD in each calen-dar year is contained in the AMSP annual reports.
PMID: 29720073 [PubMed - in process] (Source: Communicable ...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Tuberculosis notifications in Australia, 2014.
Authors: Toms C, Stapledon R, Coulter C, Douglas P
Abstract
In 2014, the National Notifiable Diseases Surveillance System received 1,339 tuberculosis (TB) notifications, representing a rate of 5.7 per 100,000 population. Australia has achieved and maintained good tuberculosis (TB) control since the mid-1980s, sustaining a low annual TB incidence rate of approximately 5 to 6 cases per 100,000 population. The number of multi-drug resistant TB (MDR-TB) cases diagnosed in Australia is low by international standards, with approximately 1-2% of notifications per year being classified as MDR-TB. Australia's overs...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Surveillance of adverse events following immunisation in Australia, 2015.
This report summarises Australian passive surveillance data for adverse events following immunisation (AEFI) for 2015 reported to the Therapeutic Goods Administration and compares them to long-term trends. There were 2,924 AEFI records for vaccines administered in 2015; an annual AEFI reporting rate of 12.3 per 100,000 population. There was a decline of 7% in the overall AEFI reporting rate in 2015 compared with 2014. This decline in reported adverse events in 2015 compared to the previous year was mainly attributable to fewer reports following the HPV vaccine and replacement of monovalent vaccines (Hib, MenCCV and varicel...
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: Prospective hospital-based surveillance for serious paediatric conditions.
Conclusions: PAEDS continues to provide unique policy-relevant data on serious paediatric conditions using hospital-based sentinel surveillance.
PMID: 29720076 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - May 4, 2018 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research
